Eric J Boren
1 Papers
Eric J Boren is an academic researcher. The author has contributed to research in topics: Adverse effect & Clinical endpoint. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Andrew Menzies-Gow,Michael E. Wechsler,Christopher E. Brightling,Stephanie Korn,Jonathan Corren,Elliot Israel,Geoffrey Chupp,Artur Bednarczyk,Sandhia Ponnarambil,Scott W Caveney,Gun Almqvist,Monika Golabek,Linda Simonsson,Kaitlyn V J Lawson,Karin Bowen,Gene L. Colice,Jorge Lima Hetzel,Jussara Fiterman,Adelmir de Souza Machado,Martti Anton Antila,Marina Andrade Lima,Suzana Erico Tanni Minamoto,Daniela Cavalet Blanco,Patrícia Gomes de Matos Bezerra,Pierre-Alain Houle,Catherine Lemière,Lyle Melenka,Richard Leigh,P. Mitchell,Syed Anees,Bonavuth Pek,Guy Chouinard,Amarjit Cheema,W. Yang,George S Rashed Philteos,Pascal Chanez,Arnaud Bourdin,Gilles Devouassoux,Camille Taillé,F. de Blay,Christophe Leroyer,Antoine Beurnier,Gilles Garcia,Pierre-Olivier Girodet,François-Xavier Blanc,Antoine Magnan,Stéphanie Wanin,Jocelyne Just,Richard Linde,Stefan Zielen,Karin Förster,Christian Gessner,Margret Jandl,Roland Buhl,M. Kornmann,A Linnhoff,Andrea Ludwig-Sengpiel,M. Ehlers,Tibor Schmoller,Heiner Steffen,Martin Hoffmann,Joachim Kirschner,Olaf Schmidt,Tobias Welte,Hilke Temme,Ori Wand,Amir Bar-Shai,Gabriel Izbicki,Neville Berkman,Gershon Fink,David Shitrit,Yochai Adir,Piotr Kuna,Barbara Rewerska,Ewa Pisarczyk-Bogacka,O M Kurbacheva,Sergey L Mikhailov,M.P. Vasilev,Alexander Emelyanov,Siraj O. Wali,Amr S. Albanna,Richard N. van Zyl-Smit,I. Abdullah,D. Bernhardi,F.M. Hoosen,Elvis M Irusen,Ismail S. Kalla,D. R. Lakha,Essack Mitha,Visvakuren Naidoo,Haylene Nell,Trevenesan Padayachee,Jeevren Reddy,F. Petrick,Eugene van der Walt,Zubar F.A. Vawda,Haein Park,Sang Haak Lee,Mi-Kyeong Kim,Jung Won Park,You Sook Cho,Byung Jae Lee,Yoon-Seok Chang,Choon-Sik Park,Kwan Ho Lee,Sook Young Lee,HyoungKyu Yoon,Kyoung Hee Sohn,Myung Jae Park,Kyung Hoon Min,Young Joo Cho,Han Ki Park,Yong gu Lee,Jaechun Lee,Chau-Chyun Sheu,Chih Yen Tu,Kang Yun Lee,Sevim Bavbek,Bilun Gemicioglu,Dane Ediger,Ilkay Koca Kalkan,Nataliia Makieieva,Mykola Ostrovskyy,Yevgeniya Dytyatkovs'ka,Yuriy Mostovoy,Kyrylo Lebed,O. Yakovenko,Atoya Adams,Timothy S. Mooring,Louis Torres Jr,Marvin E Sexton,Ernest Thompson,Jonathan A. Bernstein,P. Lisi,Christopher M Chappel,J. Cole,Gary I. Greenwald,Conigliaro Jones,Ryan M. Klein,David N. Pham,Selwyn Spangenthal,Steven F. Weinstein,H Windom,Neil L. Kao,Mila Leong,V. R. Mehta,Wendy C. Moore,Saligrama B. Bhat,Bassil Aish,Steve Meltzer,Mark H. Moss,Edward Kerwin,John Palsted Delgado,Gregg Lucksinger,Charles Thompson,S. Alpizar,Sanjay Vadgama,Z. Zafar,Joshua J. Jacobs,Njira L Lugogo,Neal Jain,Lawrence Sher,Nabil Andrawis,David Fuentes,Eric J Boren,Erika G. Gonzalez,Neetu Talreja,Sheharyar Sandy Durrani,Sudhir Sekhsaria,Samuel DeLeon,Mayank Shukla,Martha M Totszollosy Tarpay,Faisal Fakih,Golda Hudes,Jeffrey P. Tillinghast,Phillip E. Korenblat,Kartik Shenoy,Loretta G. Que,Shahrukh Ahmad Kureishy,F. C. Umeh,Vinh-Kim Nguyen,Hanh T. Chu,Thuy Thi Thu Nguyen +182 more
TL;DR: In this article , a phase 3, multicentre, randomised, double-blind, placebo-controlled, long-term extension study was conducted to evaluate the longterm safety and efficacy of tezepelumab in individuals with severe, uncontrolled asthma.
88